The administration of anti-VEGF-A-antibodies for neutralizing VEGF-A in cultured medium suppressed the migration increased by miR-141/200c overexpression in both the miR-141/200c cluster-transduced HCC-38 and miR-141/200c cluster-transduced Hs578T cells (Additional file 4: Figure S4C, F). The gene discussed is VEGFA; the disease is hepatocellular carcinoma.